Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epicatechin Pilot in Becker Muscular Dystrophy
NCT01856868Phase 2Completed
- Start
- May 2013
- Primary completion
- Sep 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Catechin in Becker muscular dystrophy (BMD). Started May 2013; status: completed.
02
Drugs
Catechin
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT01856868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856868.